Multimodal treatment of pediatric patients with Askin's tumors: our experience

World Journal of Surgical Oncology
Silvia TriaricoAntonio Ruggiero

Abstract

We report our experience and outcomes about the management of Askin's tumors [AT], which are rare primitive neuroectodermal tumors (PNETs) that develop within the soft tissue of the thoracopulmonary region, typically in children and adolescents. We retrospectively analyzed the charts of 9 patients affected by AT (aged 6-15 years), treated at the Paediatric Oncology Unit of Gemelli University Hospital in Rome between January 2001 and December 2016. All nine patients underwent to biopsy followed by neoadjuvant chemotherapy. At the end of the neoadjuvant chemotherapy, they underwent to surgical removal of the residual tumor. Five patients with positive tumor margins and/or necrosis< 90% received local radiotherapy. Two patients with metastasis received an intensified treatment, with the addition of high dose adjuvant chemotherapy followed by peripheral blood stem cells rescue. No statistically significant correlation was found between outcome and gender; the presence of any metastasis and the radiotherapy. The overall survival was 65.14 months (95% confidence interval [95%CI], 45.81-84.48), and the 5 years survival was 60%, at a median follow-up of 53.1 months. Our study confirms that a multimodal treatment with surgery, chemother...Continue Reading

References

Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P PicciP Ruggieri
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G BacciP Picci
Dec 2, 2000·The Thoracic and Cardiovascular Surgeon·S ChristiansenH H Scheld
Aug 2, 2001·Seminars in Pediatric Surgery·R C Shamberger, H E Grier
Feb 13, 2003·The Journal of Thoracic and Cardiovascular Surgery·G VeronesiU Pastorino
Apr 1, 2008·Journal of Pediatric Hematology/oncology·Hendrik van den BergJohannes Hm Merks
Jul 11, 2008·The Thoracic and Cardiovascular Surgeon·S KatsenosS Archondakis
Jan 6, 2010·Case Reports in Medicine·Gonca Kara GedikPelin Ozcan Kara
Apr 20, 2010·International Journal of Radiation Oncology, Biology, Physics·Siddhartha LaskarMary Ann Muckaden
Nov 19, 2014·The Pan African Medical Journal·Mustapha LaineAhmed Abid
Apr 18, 2015·World Journal of Surgical Oncology·Jin Yong JeongKi Jun Kim
Jun 25, 2015·Annals of Surgical Oncology·Benedetta BedettiUta Dirksen
Feb 13, 2016·Oncology Letters·K E ZhangXingya Li
May 25, 2016·Indian Journal of Surgical Oncology·L Purnima DeviAkash Handique
Jan 21, 2017·Molecular and Clinical Oncology·Suoyuan LiYingqi Hua

❮ Previous
Next ❯

Citations

Jul 23, 2019·World Journal of Surgical Oncology·Silvia TriaricoAntonio Ruggiero

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
surgical resection

Software Mentioned

SPSS©

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.